SCHEMBL28077282

SCHEMBL28077282

NS(=O)(=O)c1ccc(Nc2ccc3cccnc3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.56
CA1 P00915 9/20 0.56
CA9 Q16790 9/20 0.56
CA12 O43570 8/20 0.56
MAPT P10636 2/20 0.51
DKK1 O94907 1/20 0.51
GSK3B P49841 1/20 0.51
SOS1 Q07889 3/20 0.50
CA14 Q9ULX7 4/20 0.49
CA6 P23280 3/20 0.49
CA7 P43166 3/20 0.49
CA5A P35218 2/20 0.49
ROCK1 Q13464 1/20 0.49
CA5B Q9Y2D0 1/20 0.49
IKBKB O14920 1/20 0.47
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNA2 P20248 1/20 0.47
CCNE1 P24864 1/20 0.47
CDK2 P24941 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312967 0.83 LMNA (0.56) CA2CA1CA9CA12MEN1
SCHEMBL21101485 0.80 ALDH1A1 (0.58) MAPTKDM4EMEN1KMT2ACYP1A2
SCHEMBL28746782 0.79 LMNA (0.70) CA2CA1CA9CA12MAPT
SCHEMBL25365468 0.75 ALDH1A1 (0.52) MAPTGSK3BKDM4EMEN1KMT2A
SCHEMBL1652316 0.75 IKBKB (0.64) CA2CA1CA9CA12MAPT
SCHEMBL28168753 0.74 HDAC6 (0.58) CA2CA1CA9CA12MAPT
SCHEMBL28107398 0.74 SOS1 (0.70) CA2CA1CA9CA12SOS1
SCHEMBL9965273 0.74 NPC1 (0.64) CA2CA1CA9CA12CA14
SCHEMBL24703329 0.74 TRPV1 (0.67) MAPTMEN1KMT2ACYP1A2KDR
SCHEMBL7816978 0.73 LMNA (0.56) CA2CA1CA9CA12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105764510-A An H3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease 赛诺菲 2016-07-13 CN claimed